Insights

Expanded diagnostics MedGenome operates South Asia’s largest CAP-accredited genetic testing laboratory and offers a comprehensive test menu of over 1,300 genetic assays across key disease areas, indicating strong potential for expanding testing partnerships in oncology, inherited disorders, reproductive health, and infectious diseases with hospitals, clinics, and regional labs.

MRD and precision Recent launch of OncoTrack MRD and in-house RNA sequencing platform for Sarcoma diagnosis signal a strategic push into tumor-informed monitoring and advanced genomics capabilities, presenting opportunities to upsell MRD workflows, longitudinal monitoring contracts, and integration with oncology centers.

Public awareness Awareness campaigns such as #answersthatmatter and a digital education drive position MedGenome as a trusted partner for cascade and high-risk hereditary cancer testing, opening doors for collaboration with patient advocacy groups, insurers, and healthcare systems to expand preventive testing programs.

Strategic partnerships Acquisitions and majority investments in diagnostic chains like Green Cross Genetics Lab to widen geographic reach in India align with a channel strategy for scalable genomics services, enabling channel partnerships with regional labs, hospital networks, and multisite diagnostics providers.

Global readiness With substantial funding and revenue in the tens of millions, a broad global presence, and AI-enabled bioinformatics, MedGenome is positioned to offer enterprise-grade genomics solutions to insurers, academic medical centers, and large healthcare groups seeking integrated sequencing, analytics, and reporting platforms.

Similar companies to MEDGENOME

MEDGENOME Tech Stack

MEDGENOME uses 8 technology products and services including Google Ads, LinkedIn Ads, HubSpot Analytics, and more. Explore MEDGENOME's tech stack below.

Media & News

MEDGENOME's Email Address Formats

MEDGENOME uses at least 4 email formats:
MEDGENOME Email FormatsExamplePercentage
First.L@medgenome.comJohn.D@medgenome.com
60%
First.Last@medgenome.comJohn.Doe@medgenome.com
26%
FLast@medgenome.comJDoe@medgenome.com
8%
FirstL@medgenome.comJohnD@medgenome.com
6%

Frequently Asked Questions

What is MEDGENOME's phone number?

Minus sign iconPlus sign icon
You can contact MEDGENOME's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is MEDGENOME's official website and social media links?

Minus sign iconPlus sign icon
MEDGENOME's official website is medgenome.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does MEDGENOME generate?

Minus sign iconPlus sign icon
As of October 2026, MEDGENOME's annual revenue is estimated to be $25M - $50M.

What is MEDGENOME's SIC code and NAICS code?

Minus sign iconPlus sign icon
MEDGENOME's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does MEDGENOME have currently?

Minus sign iconPlus sign icon
As of October 2026, MEDGENOME has approximately 1K employees across 4 continents, including Asia, North America and Europe. Key team members include Chief Executive Officer (india): V. R., Cfo: S. C. and Chief Business Officer: A. C. Explore MEDGENOME's employee directory with LeadIQ.

What industry does MEDGENOME belong to?

Minus sign iconPlus sign icon
MEDGENOME operates in the Biotechnology Research industry.

What technology does MEDGENOME use?

Minus sign iconPlus sign icon
MEDGENOME's tech stack includes Google Ads, LinkedIn Ads, HubSpot Analytics, Zoho, Google Workspace, Google Cloud, Ahrefs and Piwik.

What is MEDGENOME's email format?

Minus sign iconPlus sign icon
MEDGENOME's email format typically follows the pattern of First.L@medgenome.com. Find more MEDGENOME email formats with LeadIQ.

How much funding has MEDGENOME raised to date?

Minus sign iconPlus sign icon
As of October 2026, MEDGENOME has raised $233M in funding. The last funding round occurred on Jul 21, 2025 for $48M.

When was MEDGENOME founded?

Minus sign iconPlus sign icon
MEDGENOME was founded in 2013.
MEDGENOME logo

MEDGENOME

Biotechnology ResearchKarnataka, India1001-5000 Employees

MedGenome is a biotechnology research company focused on genomics and precision diagnostics, based in Electronics City, Karnataka, India. It operates South Asia’s largest CAP-accredited genetic testing laboratory and offers a diverse menu of more than 1,300 genetic assays across key disease areas. By integrating sequencing with in-house assays and AI-enabled bioinformatics, the company translates genomic data into insights that support clinical decision-making in complex cases.

Its diagnostic capabilities span rare inherited disorders, oncology, reproductive health, infectious diseases and preventive wellness. MedGenome serves clinicians and healthcare institutions across India and multiple countries, supported by a robust research foundation and extensive collaborations. In 2026, it introduced an RNA sequencing platform for sarcoma diagnosis, reflecting ongoing expansion of its genomic diagnostics capabilities.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2013
Employees
1001-5000

Section iconFunding & Financials

  • $233M

    MEDGENOME has raised a total of $233M of funding over 9 rounds. Their latest funding round was raised on Jul 21, 2025 in the amount of $48M as a Series E.

  • $25M - $50M

    MEDGENOME's revenue is estimated to be in the range of $25M - $50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.